Glutamate levels and perfusion in pons during migraine attacks: A 3T MRI study using proton spectroscopy and arterial spin labeling.
Samaira YounisCasper E ChristensenMark B VestergaardUlrich LindbergDaniel TolnaiOlaf Bjarne PaulsonHenrik Bw LarssonAnders HougaardMessoud AshinaPublished in: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2020)
Migraine is a complex disorder, involving peripheral and central brain structures, where mechanisms and site of attack initiation are an unresolved puzzle. While abnormal pontine neuronal activation during migraine attacks has been reported, exact implication of this finding is unknown. Evidence suggests an important role of glutamate in migraine, implying a possible association of pontine hyperactivity to increased glutamate levels. Migraine without aura patients were scanned during attacks after calcitonin gene-related peptide and sildenafil in a double-blind, randomized, double-dummy, cross-over design, on two separate study days, by proton magnetic resonance spectroscopy and pseudo-continuous arterial spin labeling at 3T. Headache characteristics were recorded until 24 h after drug administrations. Twenty-six patients were scanned during migraine, yielding a total of 41 attacks. Cerebral blood flow increased in dorsolateral pons, ipsilateral to pain side during attacks, compared to outside attacks (13.6%, p = 0.009). Glutamate levels in the same area remained unchanged during attacks (p = 0.873), while total creatine levels increased (3.5%, p = 0.041). In conclusion, dorsolateral pontine activation during migraine was not associated with higher glutamate levels. However, the concurrently increased total creatine levels may suggest an altered energy metabolism, which should be investigated in future studies to elucidate the role of pons in acute migraine.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- randomized controlled trial
- magnetic resonance imaging
- prognostic factors
- spinal cord
- single molecule
- contrast enhanced
- cerebral blood flow
- clinical trial
- pulmonary hypertension
- multiple sclerosis
- magnetic resonance
- pulmonary arterial hypertension
- neuropathic pain
- transcranial direct current stimulation
- gene expression
- spinal cord injury
- working memory
- liver failure
- genome wide
- subarachnoid hemorrhage
- open label
- transcranial magnetic stimulation
- acute respiratory distress syndrome
- electronic health record
- white matter
- cerebral ischemia
- diffusion weighted imaging
- hepatitis b virus
- aortic dissection